rDEN2Δ30-7169 vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Dengue

Phase 1

Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults

CompletedNCT01931176

National Institute of Allergy and Infectious Diseases (NIAID)Dengue

Start: 2013-06-30End: 2015-05-31Updated: 2015-12-15

Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2

CompletedNCT02433652

National Institute of Allergy and Infectious Diseases (NIAID)Dengue

Start: 2015-09-30Target: 24Updated: 2018-02-28